Investor Relations

English Español Português Deutsch

Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022

View Press Release View All

May 2, 2022 • 7:15 AM EDT

Khiron Life Sciences Reports 2021 Fiscal Year End Results

Apr 27, 2022 • 5:00 PM EDT

Khiron to Host YE and Fourth Quarter 2021 Conference Call on May 2, 2022

Apr 11, 2022 • 8:25 AM EDT

Global Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in Colombia

View Presentation

Recent Events

May 11, 2022 • 1:00 pm EDT

6th Annual CG Cannabis Conference

View Event

May 3, 2022 • 2:00 pm EDT

A.G.P.’s Spring Consumer Cannabis Conference

View Event

View All

Latest Financial Results

FY 2021

Fiscal Year Ended Dec 31, 2021

Earnings Release

PDF WEB

Annual Information Form

PDF

Financial Statements

PDF

MD&A

PDF

Company Overview

Khiron Life Sciences (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMXC) is a vertically integrated global medical and CPG cannabis leader with core operations in Latin America and Europe. We currently have distribution throughout various countries in Latin America, along with activity in North America and Europe. The company is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both low and high THC medical cannabis products from Colombia to UK, Peru and Uruguay/Brazil.

View Management Team View Board of Directors

Investor Contact Information

Company

Khiron Life Sciences Corp.
100 King Street West
Suite 1600
Toronto, Ontario M5X 1A9
Canada